Nurix Therapeutics(NRIX) - 2024 Q1 - Quarterly Results
Nurix Therapeutics(NRIX)2024-04-10 11:02[Nurix logo] Exhibit 99.1 Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update Extended the Strategic Collaboration with Gilead Sciences Extended the Strategic Collaboration with Sanofi to Develop Novel Orally Available Targeted Protein Degrader of STAT6 Presented new case studies on NX-5948 demonstrating clinical responses in patients with CNS lymphoma and CLL with CNS involvement Announced that it is part of a team of experts selected as awardees in this y ...